This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cobalt Technologies Adds Bunge As Strategic Investor

MOUNTAIN VIEW, Calif., Oct. 30, 2012 /PRNewswire/ --  Cobalt Technologies ("Cobalt"), a leading developer of next generation bio-based chemicals, today announced that Bunge Global Innovation LLC, a wholly-owned subsidiary of global agribusiness and food company Bunge Limited (NYSE: BG) ("Bunge"), has joined its Series E Preferred Stock round as a strategic investor.

The investment follows Cobalt's agreement with Bunge and specialty chemicals company Rhodia Poliamida e Especialidades Ltda. ("Rhodia") to operate a pilot plant demonstrating the production of n-butanol utilizing sugarcane bagasse as feedstock at the Laboratorio Nacional de Ciencia e Tecnologia do Bioetanol facility in Campinas, Brazil.  The terms of the agreement also provide for the parties to work together on co-location of a demonstration scale facility and to consider co-location of a commercial-scale biorefinery at a Bunge sugarcane mill.  N-butanol is a widely used industrial chemical found in paints, lacquers and other surface coatings.

"We are pleased to have forged this strategic partnership with Bunge, one of the largest sugar producers in Brazil," said Bob Mayer, CEO, Cobalt Technologies.  "Bunge's investment and supply of raw material for feedstock will allow us to begin demonstrating the value of our biobutanol technology and help unlock its potential."

"Cobalt's promising technology presents the opportunity to leverage Bunge's sugarcane processing assets to produce new high-value products that diversify our revenue streams and enhance returns," said Ben Pearcy, Managing Director, Sugar & Bioenergy and Chief Development Officer, Bunge Limited.

All institutional investors from previous rounds participated in the Series E Preferred Stock round, including Pinnacle Ventures, Malaysian Life Sciences Capital Fund, VantagePoint Capital Partners, The Whittemore Collection, Ltd., Life Sciences Partners (LSP), @Ventures and Harris and Harris.  Cobalt was advised by Pacific Crest Securities.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,040.37 +29.69 0.16%
S&P 500 2,111.73 +4.34 0.21%
NASDAQ 5,082.9290 +12.9030 0.25%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs